Ramon Parsons

University of Mississippi — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

79h-index48.0kcitations299works8.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PI3K/AKT/mTOR signaling in cancer(104), Cancer-related Molecular Pathways(33), RNA modifications and cancer(33), Epigenetics and DNA Methylation(28), Genetic factors in colorectal cancer(26)

Publications299 total

A tumor-selective mRNA system enables precision cancer treatment
Molecular Therapy·2025Open Access
The impact of parent migration on education expenditures for children in rural China
Australian and International Journal of Rural Education·2025Open Access
Abstract LB243: Secreted PTEN-long downregulates PI3K signaling and PD-L1 and promotes anti-tumor antigen-presenting cell functions to cause regressions of mouse tumors
Cancer Research·2025
The BrainWaves study of adolescent wellbeing and mental health: methods development and pilot data
2025Open Access
Parental and adolescent positive affect and optimism as predictors of post-surgical mood and functioning in adolescents undergoing spinal fusion surgery
2025Open Access
The BrainWaves study of adolescent wellbeing and mental health: methods development and pilot data
2025Open Access
The BrainWaves study of adolescent wellbeing and mental health: methods development and pilot data
2025Open Access
Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system
Nature Materials·2025· 82 cited
Harnessing the TAF1 Acetyltransferase for Targeted Acetylation of the Tumor Suppressor p53
Advanced Science·2024· 5 citedOpen Access
Design, Synthesis, and Evaluation of p53Y220C Acetylation Targeting Chimeras (AceTACs)
Journal of Medicinal Chemistry·2024· 7 citedOpen Access
Basal p53 maintains a distinct transcriptional program from irradiated p53 in tissue, including tumor suppressors
2024
Differential histone acetylation and super-enhancer regulation underlie melanoma cell dedifferentiation
JCI Insight·2024· 3 citedOpen Access
Molecular mechanisms in colitis-associated colorectal cancer
Oncogenesis·2023· 71 citedOpen Access
Etiology of super-enhancer reprogramming and activation in cancer
Epigenetics & Chromatin·2023· 23 citedOpen Access
Acetylation Targeting Chimera Enables Acetylation of the Tumor Suppressor p53
Journal of the American Chemical Society·2023· 52 citedOpen Access
AKT activation because of PTEN loss upregulates xCT via GSK3β/NRF2, leading to inhibition of ferroptosis in PTEN-mutant tumor cells
Cell Reports·2023· 43 citedOpen Access
<scp>B7‐H3</scp> drives immunosuppression and Co‐targeting with <scp>CD47</scp> is a new therapeutic strategy in β‐catenin activated melanomas
Pigment Cell & Melanoma Research·2023· 6 cited
Author Correction: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma
Nature Communications·2023Open Access
Abstract 3481: A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma
Cancer Research·2023
Supplementary Data from AKT Degradation Selectively Inhibits the Growth of PI3K/PTEN Pathway–Mutant Cancers with Wild-Type KRAS and BRAF by Destabilizing Aurora Kinase B
2023Open Access
page 1 of 15Next →

Frequent Co-authors

Kenneth W. Kinzler(10), Bert Vogelstein(10), Hanina Hibshoosh(8), Sanford D. Markowitz(7), James K. V. Willson(7), Nickolas Papadopoulos(6), Bo Liu(6), Stanley R. Hamilton(6), Jin Jen(5), Charis Eng(5), Lao H. Saal(5), Lorenzo Memeo(5), Katrina Podsypanina(4), Steven I. Wang(4), Janusz Puc(4), Nicholas C. Nicolaides(4), Tao Su(4), K W Kinzler(3), Jing Li(3), Danny Liaw(3)